Triheptanoin partially restores levels of tricarboxylic acid cycle intermediates in the mouse pilocarpine model of epilepsy - PubMed (original) (raw)

. 2014 Apr;129(1):107-19.

doi: 10.1111/jnc.12610. Epub 2013 Dec 2.

Affiliations

• PMID: 24236946
• DOI: 10.1111/jnc.12610

Free article

Triheptanoin partially restores levels of tricarboxylic acid cycle intermediates in the mouse pilocarpine model of epilepsy

Mussie G Hadera et al. J Neurochem. 2014 Apr.

Free article

Abstract

Triheptanoin, the triglyceride of heptanoate, is anticonvulsant in various epilepsy models. It is thought to improve energy metabolism in the epileptic brain by re-filling the tricarboxylic acid (TCA) cycle with C4-intermediates (anaplerosis). Here, we injected mice with [1,2-(13) C]glucose 3.5-4 weeks after pilocarpine-induced status epilepticus (SE) fed either a control or triheptanoin diet. Amounts of metabolites and incorporations of (13) C were determined in extracts of cerebral cortices and hippocampal formation and enzyme activity and mRNA expression were quantified. The percentage enrichment with two (13) C atoms in malate, citrate, succinate, and GABA was reduced in hippocampal formation of control-fed SE compared with control mice. Except for succinate, these reductions were not found in triheptanoin-fed SE mice, indicating that triheptanoin prevented a decrease of TCA cycle capacity. Compared to those on control diet, triheptanoin-fed SE mice showed few changes in most other metabolite levels and their (13) C labeling. Reduced pyruvate carboxylase mRNA and enzyme activity in forebrains and decreased [2,3-(13) C]aspartate amounts in cortex suggest a pyruvate carboxylation independent source of C-4 TCA cycle intermediates. Most likely anaplerosis was kept unchanged by carboxylation of propionyl-CoA derived from heptanoate. Further studies are proposed to fully understand triheptanoin's effects on neuroglial metabolism and interaction.

Keywords: 13C isotope; NMR spectroscopy; anaplerosis; medium chain triglyceride; seizures; status epilepticus.

© 2013 International Society for Neurochemistry.

PubMed Disclaimer

Similar articles

• Triheptanoin alters [U-13C6]-glucose incorporation into glycolytic intermediates and increases TCA cycling by normalizing the activities of pyruvate dehydrogenase and oxoglutarate dehydrogenase in a chronic epilepsy mouse model.
  McDonald T, Hodson MP, Bederman I, Puchowicz M, Borges K. McDonald T, et al. J Cereb Blood Flow Metab. 2020 Mar;40(3):678-691. doi: 10.1177/0271678X19837380. Epub 2019 Mar 19. J Cereb Blood Flow Metab. 2020. PMID: 30890077 Free PMC article.
• Anticonvulsant effects of a triheptanoin diet in two mouse chronic seizure models.
  Willis S, Stoll J, Sweetman L, Borges K. Willis S, et al. Neurobiol Dis. 2010 Dec;40(3):565-72. doi: 10.1016/j.nbd.2010.07.017. Epub 2010 Aug 4. Neurobiol Dis. 2010. PMID: 20691264 Free PMC article.
• Triheptanoin protects against status epilepticus-induced hippocampal mitochondrial dysfunctions, oxidative stress and neuronal degeneration.
  Tan KN, Simmons D, Carrasco-Pozo C, Borges K. Tan KN, et al. J Neurochem. 2018 Feb;144(4):431-442. doi: 10.1111/jnc.14275. Epub 2018 Jan 3. J Neurochem. 2018. PMID: 29222946
• Triheptanoin--a medium chain triglyceride with odd chain fatty acids: a new anaplerotic anticonvulsant treatment?
  Borges K, Sonnewald U. Borges K, et al. Epilepsy Res. 2012 Jul;100(3):239-44. doi: 10.1016/j.eplepsyres.2011.05.023. Epub 2011 Aug 19. Epilepsy Res. 2012. PMID: 21855298 Free PMC article. Review.
• Modification of Astrocyte Metabolism as an Approach to the Treatment of Epilepsy: Triheptanoin and Acetyl-L-Carnitine.
  Hadera MG, McDonald T, Smeland OB, Meisingset TW, Eloqayli H, Jaradat S, Borges K, Sonnewald U. Hadera MG, et al. Neurochem Res. 2016 Feb;41(1-2):86-95. doi: 10.1007/s11064-015-1728-5. Epub 2015 Oct 3. Neurochem Res. 2016. PMID: 26433381 Review.

Cited by

• Metabolic Alterations in Developing Brain After Injury: Knowns and Unknowns.
  McKenna MC, Scafidi S, Robertson CL. McKenna MC, et al. Neurochem Res. 2015 Dec;40(12):2527-43. doi: 10.1007/s11064-015-1600-7. Epub 2015 Jul 7. Neurochem Res. 2015. PMID: 26148530 Free PMC article. Review.
• Ketogenic diets, mitochondria, and neurological diseases.
  Gano LB, Patel M, Rho JM. Gano LB, et al. J Lipid Res. 2014 Nov;55(11):2211-28. doi: 10.1194/jlr.R048975. Epub 2014 May 20. J Lipid Res. 2014. PMID: 24847102 Free PMC article. Review.
• Open-label long-term treatment of add-on triheptanoin in adults with drug-resistant epilepsy.
  Borges K, Kaul N, Germaine J, Carrasco-Pozo C, Kwan P, O'Brien TJ. Borges K, et al. Epilepsia Open. 2020 Apr 12;5(2):230-239. doi: 10.1002/epi4.12391. eCollection 2020 Jun. Epilepsia Open. 2020. PMID: 32524048 Free PMC article.
• Medium-Chain Fatty Acids, Beta-Hydroxybutyric Acid and Genetic Modulation of the Carnitine Shuttle Are Protective in a Drosophila Model of ALS Based on TDP-43.
  Manzo E, O'Conner AG, Barrows JM, Shreiner DD, Birchak GJ, Zarnescu DC. Manzo E, et al. Front Mol Neurosci. 2018 May 31;11:182. doi: 10.3389/fnmol.2018.00182. eCollection 2018. Front Mol Neurosci. 2018. PMID: 29904341 Free PMC article.
• Effects of ketogenic diets on the occurrence of pilocarpine-induced status epilepticus of rats.
  Gama IR, Trindade-Filho EM, Oliveira SL, Bueno NB, Melo IT, Cabral-Junior CR, Barros EM, Galvão JA, Pereira WS, Ferreira RC, Domingos BR, da Rocha Ataide T. Gama IR, et al. Metab Brain Dis. 2015 Feb;30(1):93-8. doi: 10.1007/s11011-014-9586-4. Epub 2014 Jul 9. Metab Brain Dis. 2015. PMID: 25005004

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Wiley

• Other Literature Sources

  • The Lens - Patent Citations Database
  • scite Smart Citations

• Medical

  • MedlinePlus Consumer Health Information
  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal